FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2084326063> ?p ?o ?g. }

• W2084326063 endingPage "3926" @default.
• W2084326063 startingPage "3921" @default.
• W2084326063 abstract "Acute graft-versus-host disease (GVHD) and leukemic relapse are the two major obstacles to successful outcomes after allogeneic bone marrow transplantation (BMT), an effective therapy for hematological malignancies. Several studies have demonstrated that the dysregulation of proinflammatory cytokines and the loss of gastrointestinal tract integrity contribute to GVHD, whereas the donor cytotoxic responses are critical for graft-versus-leukemia (GVL) preservation. Suberoylanilide hydroxamic acid (SAHA) is currently in clinical trials as an antitumor agent; it inhibits the activity of histone deacetylases and at low doses exhibits antiinflammatory effects by reducing the production of proinflammatory cytokines. Using two well characterized mouse models of BMT, we have studied the effects of SAHA on GVHD severity and GVL activity. Administration of SAHA from day +3 to day +7 after BMT reduced serum levels of the proinflammatory cytokines and decreased intestinal histopathology, clinical severity, and mortality from acute GVHD compared with vehicle-treated animals. However, SAHA had no effect on donor T cell proliferative and cytotoxic responses to host antigens in vivo or in vitro . When mice received lethal doses of tumor cells at the time of BMT, administration of SAHA did not impair GVL activity and resulted in significantly improved leukemia-free survival by using two different tumor and donor/recipient combinations. These findings reveal a critical role for histone deacetylase inhibition in the proinflammatory events contributing to GVHD and suggest that this class of pharmacologic agents may provide a strategy to reduce GVHD while preserving cytotoxic T cell responses to host antigens and maintaining beneficial GVL effects." @default.
• W2084326063 created "2016-06-24" @default.
• W2084326063 creator A5003360183 @default.
• W2084326063 creator A5021537282 @default.
• W2084326063 creator A5023099227 @default.
• W2084326063 creator A5025889209 @default.
• W2084326063 creator A5028234430 @default.
• W2084326063 creator A5054315063 @default.
• W2084326063 creator A5078441495 @default.
• W2084326063 date "2004-03-04" @default.
• W2084326063 modified "2023-10-16" @default.
• W2084326063 title "Histone deacetylase inhibitor suberoylanilide hydroxamic acid reduces acute graft-versus-host disease and preserves graft-versus-leukemia effect" @default.
• W2084326063 cites W1510351486 @default.
• W2084326063 cites W1510827637 @default.
• W2084326063 cites W1608695296 @default.
• W2084326063 cites W1647478418 @default.
• W2084326063 cites W1795844187 @default.
• W2084326063 cites W1812576394 @default.
• W2084326063 cites W1895939501 @default.
• W2084326063 cites W1992613163 @default.
• W2084326063 cites W2005908911 @default.
• W2084326063 cites W2020672759 @default.
• W2084326063 cites W2022285476 @default.
• W2084326063 cites W2036334656 @default.
• W2084326063 cites W2036736974 @default.
• W2084326063 cites W2069669865 @default.
• W2084326063 cites W2094400037 @default.
• W2084326063 cites W2108639843 @default.
• W2084326063 cites W2122509690 @default.
• W2084326063 cites W2129379081 @default.
• W2084326063 cites W2131187278 @default.
• W2084326063 cites W2139823699 @default.
• W2084326063 cites W2153838226 @default.
• W2084326063 cites W2161667744 @default.
• W2084326063 cites W2166338481 @default.
• W2084326063 cites W2167415368 @default.
• W2084326063 cites W2294608654 @default.
• W2084326063 cites W2323339045 @default.
• W2084326063 cites W2443505819 @default.
• W2084326063 cites W4233036449 @default.
• W2084326063 cites W4242388067 @default.
• W2084326063 cites W4244712895 @default.
• W2084326063 cites W4251934001 @default.
• W2084326063 cites W4256235973 @default.
• W2084326063 doi "https://doi.org/10.1073/pnas.0400380101" @default.
• W2084326063 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/374345" @default.
• W2084326063 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15001702" @default.
• W2084326063 hasPublicationYear "2004" @default.
• W2084326063 type Work @default.
• W2084326063 sameAs 2084326063 @default.
• W2084326063 citedByCount "252" @default.
• W2084326063 countsByYear W20843260632012 @default.
• W2084326063 countsByYear W20843260632013 @default.
• W2084326063 countsByYear W20843260632014 @default.
• W2084326063 countsByYear W20843260632015 @default.
• W2084326063 countsByYear W20843260632016 @default.
• W2084326063 countsByYear W20843260632017 @default.
• W2084326063 countsByYear W20843260632018 @default.
• W2084326063 countsByYear W20843260632019 @default.
• W2084326063 countsByYear W20843260632020 @default.
• W2084326063 countsByYear W20843260632021 @default.
• W2084326063 countsByYear W20843260632022 @default.
• W2084326063 countsByYear W20843260632023 @default.
• W2084326063 crossrefType "journal-article" @default.
• W2084326063 hasAuthorship W2084326063A5003360183 @default.
• W2084326063 hasAuthorship W2084326063A5021537282 @default.
• W2084326063 hasAuthorship W2084326063A5023099227 @default.
• W2084326063 hasAuthorship W2084326063A5025889209 @default.
• W2084326063 hasAuthorship W2084326063A5028234430 @default.
• W2084326063 hasAuthorship W2084326063A5054315063 @default.
• W2084326063 hasAuthorship W2084326063A5078441495 @default.
• W2084326063 hasBestOaLocation W20843260632 @default.
• W2084326063 hasConcept C104317684 @default.
• W2084326063 hasConcept C126322002 @default.
• W2084326063 hasConcept C154317977 @default.
• W2084326063 hasConcept C164027704 @default.
• W2084326063 hasConcept C202751555 @default.
• W2084326063 hasConcept C203014093 @default.
• W2084326063 hasConcept C2776202225 @default.
• W2084326063 hasConcept C2776914184 @default.
• W2084326063 hasConcept C2778305200 @default.
• W2084326063 hasConcept C2778461978 @default.
• W2084326063 hasConcept C2779972918 @default.
• W2084326063 hasConcept C2911091166 @default.
• W2084326063 hasConcept C502942594 @default.
• W2084326063 hasConcept C55493867 @default.
• W2084326063 hasConcept C64927066 @default.
• W2084326063 hasConcept C71924100 @default.
• W2084326063 hasConcept C86803240 @default.
• W2084326063 hasConcept C98274493 @default.
• W2084326063 hasConceptScore W2084326063C104317684 @default.
• W2084326063 hasConceptScore W2084326063C126322002 @default.
• W2084326063 hasConceptScore W2084326063C154317977 @default.
• W2084326063 hasConceptScore W2084326063C164027704 @default.
• W2084326063 hasConceptScore W2084326063C202751555 @default.
• W2084326063 hasConceptScore W2084326063C203014093 @default.
• W2084326063 hasConceptScore W2084326063C2776202225 @default.
• W2084326063 hasConceptScore W2084326063C2776914184 @default.

• next